Jerome Riebman MD, MA
EVP, Clinical Development & Medical Affairs
Dr. Riebman has extensive executive expertise in the cardiac pharmaceutical industry with strategic leadership, innovation and commercialization skills. With over 40 years clinical, industry and academic experience, he has served in leadership positions at Aziyo Biologics, Amgen, Novartis Pharmaceuticals and J&J’s Ethicon Biosurgery. Dr. Riebman’s clinical experience focused on Cardiovascular and Thoracic Surgery with heart transplantation and heart assist devices. He served as clinical investigator for NIH, NHLBI and industry-sponsored research, has over 120 professional publications and 59 presentations to his credit, and is the inventor on 19 medical device patents. Dr. Riebman received his MD, MA in Biology and completed a General Surgery residency at Temple University, followed by a NHLBI research fellowship at University of Utah’s Artificial Heart Lab, and a Cardiothoracic and Vascular Surgery residency at McGill University. He was board certified in both General Surgery and Thoracic Surgery and is a Fellow of the American College of Surgeons and the American College of Cardiology.